24 April 2021, 12:37 PM | Reuters | @SABCNews
Image: ReutersMalaysia has secured a total of 12.8 million doses from AstraZeneca, half of which will come via the global COVAX facility.
Malaysia received 268 800 doses of AstraZeneca vaccines on Friday night, its first batch from the pharmaceutical company, the state news agency reported on Saturday.
Health Minister Adham Baba said the batch was purchased through the COVAX facility.
“The COVAX facility sent the vaccine from South Korea, and we will keep it at the designated storage centre,” he told reporters, according to
Bernama.
The country had initially given conditional approval in March for the use of the vaccine made by the firm, but placed it under review after the European Medicines Agency found that unusual blood clots with low blood platelets was a rare side effect of the vaccine.
Chilean AstraZeneca trial saw no cases of blood clots - trial leaders
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
No blood clots among 2,200 Chilean participants in AstraZeneca COVID-19 vaccine trial – trial leaders
sharenet.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sharenet.co.za Daily Mail and Mail on Sunday newspapers.
Article content
SANTIAGO Chilean investigators testing the AstraZeneca-Oxford University COVID-19 vaccination in 2,200 people found no instances of blood clots among participants, they said on Friday.
Dr. Maria Elena Santolaya, from the University of Chile which led the trial, said the study included people of all ages, with 20% of them over 60 years old.
We apologize, but this video has failed to load.
Try refreshing your browser, or Chilean AstraZeneca trial saw no cases of blood clots - trial leaders Back to video
“In no age group, among women or men, did we have any blood clotting of any nature,” she said.